ACR Convergence:
The American College of Rheumatology (ACR) 2026 annual conference
November 6 - 11 | Orlando, FL
ACR Convergence:
The American College of Rheumatology (ACR) 2026 annual conference
At Miltenyi Biotec, transforming the treatment landscape for autoimmune diseases requires moving cutting-edge science from the laboratory to patient. For over 35 years, we have empowered clinicians with our technology and contract development and manufacturing organization (CDMO) services that support their cell therapy workflows. As cell therapies emerge for severe, refractory autoimmune conditions, you can rely on Miltenyi Biotec for robust, automated, and flexible cell-therapy-manufacturing solutions that will safely and efficiently translate your innovative cell therapies from the research stage into clinical arena.
During ACR Convergence 2026, make sure you visit us at booth 2331.
- Explore the CliniMACS Prodigy®: Discover how this closed, automated system enables standardized cell therapy manufacturing right at your institution
- Connect with our clinical experts: Discuss your specific clinical trial protocols, target indications, and research challenges with our specialized scientific team
- Leverage 25+ years of GMP expertise: Learn how our comprehensive portfolio of MACS® GMP Reagents and regulatory support can smooth your transition from discovery to bedside
- Take advantage of the MACS® Catalyst Program™: Explore how this program helps lower operational barriers, accelerating your access to world-class cell manufacturing technology and expertise
Support at every stage with complete CGT workflows
Understanding autoimmune disease and cell therapy options
A new era of cell therapy for autoimmune diseases is underway. As promising clinical results drive the field toward pivotal studies and commercialization, developers face increasing demands for scalable, reproducible, and compliant manufacturing. Miltenyi Biotec empowers innovators with proven cell-processing technologies and integrated-manufacturing solutions that help translate clinical success into broader patient access.
Key resources
As cell therapies gain momentum across autoimmune indications, robust manufacturing and translational workflows are becoming increasingly important to clinical success. Access publications, webinars, and scientific resources that showcase advances in autoimmune cell therapy research, clinical development, and manufacturing, supported by technologies from Miltenyi Biotec.
Contact our experts
Share your details below and our team will be in touch shortly
You have previously chosen International as your location.
What do you want to do?